NANOATHERO

Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility

assignment_turned_inproject01 Feb 2013(Started)-31 Jul 2018(Ended)Closed

Funder: European CommissionProject code: 309820 Call for proposal: FP7-NMP-2012-LARGE-6

Funded under: FP7 | SP1 | NMP

Detailed project information (CORDIS)

visibility

download

views

downloads

NANOATHERO

- Summary
- DMPs
- Metrics

Partners

CEA , BRACCO , AP-HP , University of Twente , NanoPET Pharma (Germany) , WINZSOFT (ISRAEL) LTD , Semmelweis University , AMC , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE , MPG , Universitätsklinikum Erlangen , Edinethics , MUG , SDU , CLINAM , Inserm Transfert

Data Management Plans

Start a new DMP in Argos

Usage byUsageCounts
visibility views 14
download downloads 32
14
views
32
downloads
Powered by

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda_______::ea60dfdee64a02b6d5536c75f2575a00&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

NANOATHERO

NANOATHERO

Loading